Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.72−0.02 (-2.78%)
Close on Nov 18, 2026Market cap $66.69MP/E –Yield –
Anavex Life Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Anavex Life Sciences's market cap was $98.26M on Nov 11, 2026, against $331.94M a year earlier. Over the last 5 years it ranged from $98.26M to $1.32B, with a median of $654.17M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $98.26M | -68.2% |
| 2025 | Dec 31, 2025 | $308.54M | -66.1% |
| 2024 | Dec 31, 2024 | $910.70M | +19.2% |
| 2023 | Dec 29, 2023 | $764.04M | +5.9% |
| 2022 | Dec 30, 2022 | $721.75M | -45.2% |
| 2021 | Dec 31, 2021 | $1.32B | +292.9% |
| 2020 | Dec 31, 2020 | $335.04M | +145.7% |
| 2019 | Dec 31, 2019 | $136.36M | +90.3% |
| 2018 | Dec 31, 2018 | $71.66M | -48.6% |
| 2017 | Dec 29, 2017 | $139.53M | -2.6% |
| 2016 | Dec 30, 2016 | $143.23M | -19.8% |
| 2015 | Dec 31, 2015 | $178.49M | +1890.2% |
| 2014 | Dec 31, 2014 | $8.97M | -3.7% |
| 2013 | Dec 31, 2013 | $9.31M | -61.0% |
| 2012 | Dec 31, 2012 | $23.89M | -26.3% |
| 2011 | Dec 30, 2011 | $32.42M | -62.2% |
| 2010 | Dec 31, 2010 | $85.84M | – |
See a number that looks wrong?